Covid-19 vaccine for children likely in August: Health minister Mandaviya
Zydus Cadila has done trials on 12-plus; Bharat Biotech conducting trials on two-plus27-07-2021
27-07-2021
Zydus Cadila gets tentative approval from USFDA to market cancer drug
Drug firm Zydus Cadila on Wednesday said it has received tentative approval from the US health regulator to market Ibrutinib tablets used in the treatment of certain types of cancers.21-07-2021
CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus Cadila receives tentative approval from the USFDA for Ibrutinib Tablets21-07-2021
CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
European Medicines Agency grants Orphan Drug Designation to Saroglitazar Mg for the treatment of patients with Primary Biliary Cholangitis (PBC)21-07-2021
CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Newspaper Publication
News paper publication of AGM Notice of the Company19-07-2021
Zydus Cadila plans to start vaccine trials on children above 5 yrs soon
Review of company's Covid vaccine candidate, ZyCoV-D, may be taken up by the SEC this week18-07-2021
Zydus Cadila's COVID-19 vaccine for 12-18 year olds to be available soon: Centre
Zydus Cadila TEMPhas completed its trial for children aged between 12 and 18 years and is subject to statutory approvals, teh government said in an affidavit submitted with teh Delhi High Court16-07-2021
Cadila arm completes sale of animal health business for Rs 2,921 crore
Cadila Healthcare on Thursday said its wholly-owned subsidiary Zydus Animal Health and Investment has completed sale of its animal healthcare established markets15-07-2021
Cadila Healthcare Ltd - 532321 - Updates On Sale / Disposal Of An Undertaking Of A Wholly Owned Subsidiary
Intimation under regulation 30(7) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('the Listing Regulations')15-07-2021